What is the recommended protocol for weaning off Celexa (citalopram)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Weaning Protocol for Citalopram (Celexa)

The recommended protocol for weaning off Celexa (citalopram) is a gradual reduction in dose over 10 to 14 days to limit withdrawal symptoms. 1

General Tapering Principles

  • Abrupt discontinuation of citalopram should be avoided as it may cause withdrawal symptoms; a gradual reduction in dose rather than abrupt cessation is recommended whenever possible 2
  • The standard tapering period for antidepressants is 10-14 days, which helps limit withdrawal symptoms while ensuring safe discontinuation 1
  • If intolerable symptoms occur during dose reduction, resuming the previously prescribed dose may be considered, followed by continuing the taper at a more gradual rate 2

Specific Tapering Protocol

  • For patients on standard doses (20-40 mg/day), reduce the dose by approximately 10-20% every 2-4 days 1, 2
  • A common approach is to decrease from 40 mg to 30 mg, then to 20 mg, then to 10 mg, and finally to discontinuation, with each step lasting 3-4 days 2
  • For patients on the maximum dose of 40 mg/day, a more conservative approach may be needed with smaller incremental reductions 2
  • For elderly patients (>60 years) who are typically on lower doses (maximum 20 mg/day), even more gradual tapering may be appropriate 2

Monitoring During Tapering

  • Monitor for withdrawal symptoms which may include dizziness, nausea, headache, paresthesia, irritability, anxiety, and sleep disturbances 1
  • If withdrawal symptoms become severe or intolerable, slow the tapering schedule by making smaller reductions or extending the time between dose decreases 2
  • Patients with a history of severe depression may need closer monitoring during the tapering process to watch for signs of relapse 1

Special Considerations

  • Patients who have been on citalopram for longer periods (months to years) may require a more extended tapering schedule than the standard 10-14 days 1
  • Those with a history of antidepressant discontinuation syndrome may benefit from an even more gradual taper 1
  • For patients with comorbid anxiety disorders, a slower taper may be necessary to prevent exacerbation of anxiety symptoms 1

Potential Withdrawal Symptoms

  • Common withdrawal symptoms include flu-like symptoms, insomnia, nausea, imbalance, sensory disturbances, and hyperarousal 1
  • These symptoms typically begin within 1-3 days of dose reduction and may last 1-2 weeks 1
  • Distinguishing between withdrawal symptoms and depression recurrence is important - withdrawal symptoms typically emerge quickly after dose reduction and diminish over time, while recurrence develops more gradually and persists 1

When to Seek Additional Help

  • If severe withdrawal symptoms occur despite a gradual taper, consult with a healthcare provider about adjusting the tapering schedule 2
  • If signs of depression recurrence emerge (persistent low mood, anhedonia, changes in sleep/appetite lasting more than two weeks), prompt medical evaluation is needed 1
  • Suicidal thoughts or severe mood disturbances during tapering warrant immediate medical attention 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.